If you made any changes in Pure these will be visible here soon.

Personal profile


  • Diabetes
  • Diabetic complications
  • diabetic nephropathy
  • cardiovascular disease
  • oxidative stress
  • reactive oxygen species
  • unstable plaque

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2021

Research Output 2004 2018

Lipoxins regulate the early growth response-1 network and reverse diabetic kidney disease

Brennan, E. P., Mohan, M., McClelland, A., Tikellis, C., Ziemann, M., Kaspi, A., Gray, S. P., Pickering, R., Tan, S. M., Tasadaque Ali-Shah, S., Guiry, P. J., El-Osta, A., Jandeleit-Dahm, K., Cooper, M. E., Godson, C. & Kantharidis, P. 1 May 2018 In : Journal of the American Society of Nephrology. 29, 5, p. 1437-1448 12 p.

Research output: Contribution to journalArticleResearchpeer-review

SGLT-2 Inhibition: Novel Therapeutics for Reno-and Cardioprotection in Diabetes Mellitus

Gill, A., Gray, S., Jandeleit-Dahm, K. & Watson, A. M. D. 17 Apr 2018 (Accepted/In press) In : Current Diabetes Reviews.

Research output: Contribution to journalReview ArticleOtherpeer-review

Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease

Gray, S. P., Jha, J. C., Kennedy, K., Bommel, E. V., Chew, P., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E. & Jandeleit-Dahm, K. A. M. May 2017 In : Diabetologia. 60, 5, p. 927-937 11 p.

Research output: Contribution to journalArticleResearchpeer-review

GLP-1 receptor agonists: An example of the challenge for animal models to predict plaque instability/rupture and cardiovascular outcomes

Ying, Y. L., Chen, Y. C., Jandeleit-Dahm, K. & Peter, K. 1 Oct 2017 In : Atherosclerosis. 265, p. 250-252 3 p.

Research output: Contribution to journalEditorialOtherpeer-review